Abstract
Several clinical trials are testing whether human papillomavirus (HPV) vaccines can ultimately be used to eradicate cervical cancer. Two of the more than 30 sexually transmitted HPV types, HPV-16 and HPV-18, cause more than 70% of the disease that kills 250,000 women worldwide each year.